Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top

Cancer Microenvironment

Issue 3/2014

Special Issue on Circulating Tumor Cells

Content (7 Articles)

Introduction

About Seed and Soil

Patrizia Paterlini-Bréchot

Review Paper

Pivotal Role of Pervasive Neoplastic and Stromal Cells Reprogramming in Circulating Tumor Cells Dissemination and Metastatic Colonization

Didier Meseure, Kinan Drak Alsibai, Andre Nicolas

Original Papers

Microenvironmental Influences on Metastasis Suppressor Expression and Function during a Metastatic Cell’s Journey

Wen Liu, Carolyn J. Vivian, Amanda E. Brinker, Kelsey R. Hampton, Evi Lianidou, Danny R. Welch

Original Article

Orthotopic Mouse Models of Tumor Metastasis Expressing Fluorescent Reporters Produce Imageable Circulating Tumor Cells

Robert M. Hoffman

Original Paper

Angiotropism, Pericytic Mimicry and Extravascular Migratory Metastasis in Melanoma: An Alternative to Intravascular Cancer Dissemination

Claire Lugassy, Sohila Zadran, Laurent A. Bentolila, Madhuri Wadehra, Roshini Prakash, S. Thomas Carmichael, Hynda K. Kleinman, Bruno Péault, Lionel Larue, Raymond L. Barnhill

Original Paper

Crosstalk between CTC, Immune System and Hypoxic Tumor Microenvironment

Muhammad Zaeem Noman, Yosra Messai, Jane Muret, Meriem Hasmim, Salem Chouaib

Open Access ORIGINAL PAPER

Circulating Tumor Cells: Who is the Killer?

Patrizia Paterlini-Bréchot

Aug 14
Issue: 1-2/2014
Apr 15
Issue: 1/2015

Latest issues

scroll for more

use your arrow keys for more

scroll or use arrow keys for more

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits